Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | -37.71%702 | -12.51%4.13K | -17.82%807 | -28.51%1.08K | -2.52%1.12K | 3.97%1.13K | -0.96%4.72K | -17.27%982 | 4.43%1.51K | 1.41%1.15K |
| Gross profit | 37.71%-702 | 12.51%-4.13K | 17.82%-807 | 28.51%-1.08K | 2.52%-1.12K | -3.97%-1.13K | 0.96%-4.72K | 17.27%-982 | -4.43%-1.51K | -1.41%-1.15K |
| Operating expense | -26.71%45.78K | -20.06%264.76K | -40.68%70.62K | -4.37%70.46K | -20.10%61.22K | 1.01%62.47K | -33.02%331.18K | -37.91%119.05K | 6.95%73.67K | -46.09%76.61K |
| Selling and administrative expenses | -16.41%45.78K | -10.54%233.7K | -33.73%50.26K | 5.76%69.62K | -9.37%59.04K | 0.67%54.77K | -14.52%261.23K | 33.58%75.84K | 7.46%65.84K | -51.29%65.14K |
| -General and administrative expense | -16.41%45.78K | -10.54%233.7K | -33.73%50.26K | 5.76%69.62K | -9.37%59.04K | 0.67%54.77K | -14.52%261.23K | 33.58%75.84K | 7.46%65.84K | -51.29%65.14K |
| Other operating expenses | ---- | -55.60%31.06K | -52.89%20.36K | -89.40%831 | -81.03%2.18K | 3.54%7.7K | -62.96%69.95K | -67.98%43.21K | 2.78%7.84K | 36.81%11.47K |
| Operating profit | 26.90%-46.49K | 19.95%-268.89K | 40.50%-71.42K | 4.85%-71.53K | 19.84%-62.34K | -1.06%-63.6K | 32.71%-335.9K | 37.78%-120.03K | -6.89%-75.18K | 45.71%-77.76K |
| Net non-operating interest income (expenses) | -308 | 0 | ||||||||
| Non-operating interest expense | --308 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other net income (expenses) | -242.27%-2.89K | 109.28%3.76K | 122.28%6.42K | -76.23%1.55K | 19.54%-6.24K | 119.47%2.03K | -19.45%-40.49K | -132.59%-28.82K | 106.43%6.51K | 89.88%-7.76K |
| Gain on sale of security | -242.27%-2.89K | 99.93%-30 | 122.31%6.43K | -134.58%-2.25K | 19.54%-6.24K | 119.47%2.03K | -19.45%-40.49K | -132.59%-28.82K | 106.43%6.51K | 89.88%-7.76K |
| Special income (charges) | ---- | --3.79K | ---11 | --3.8K | ---- | ---- | --0 | --0 | --0 | ---- |
| -Gain on sale of property,plant,equipment | ---- | --3.79K | ---11 | --3.8K | ---- | ---- | --0 | --0 | --0 | ---- |
| Income before tax | 19.30%-49.68K | 29.56%-265.13K | 56.33%-65.01K | -1.91%-69.99K | 19.81%-68.58K | 16.07%-61.57K | 29.40%-376.39K | -42.44%-148.85K | 59.95%-68.67K | 61.10%-85.52K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 19.30%-49.68K | 29.56%-265.13K | 56.33%-65.01K | -1.91%-69.99K | 19.81%-68.58K | 16.07%-61.57K | 29.40%-376.39K | -42.44%-148.85K | 59.95%-68.67K | 61.10%-85.52K |
| Net income continuous operations | 19.30%-49.68K | 29.56%-265.13K | 56.33%-65.01K | -1.91%-69.99K | 19.81%-68.58K | 16.07%-61.57K | 29.40%-376.39K | -42.44%-148.85K | 59.95%-68.67K | 61.10%-85.52K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 19.30%-49.68K | 29.56%-265.13K | 56.33%-65.01K | -1.91%-69.99K | 19.81%-68.58K | 16.07%-61.57K | 29.40%-376.39K | -42.44%-148.85K | 59.95%-68.67K | 61.10%-85.52K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 19.30%-49.68K | 29.56%-265.13K | 56.33%-65.01K | -1.91%-69.99K | 19.81%-68.58K | 16.07%-61.57K | 29.40%-376.39K | -42.44%-148.85K | 59.95%-68.67K | 61.10%-85.52K |
| Diluted earnings per share | 0 | 0 | 169.39%0.0039 | -1.88%-0.0014 | 0 | 0 | 0.00%-0.01 | -0.0056 | 59.95%-0.0013 | 0 |
| Basic earnings per share | 0 | 0 | 169.39%0.0039 | -1.88%-0.0014 | 0 | 0 | 0.00%-0.01 | -0.0056 | 59.95%-0.0013 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.